GoodRx Holdings, Inc. (NASDAQ:GDRX) Q3 2022 Earnings Conference Call November 8, 2022 5:00 PM ET

Company Participants

Whitney Notaro – Vice President-Investor Relations

Doug Hirsch – Co-Founder and Co-Chief Executive Officer

Trevor Bezdek – Co-Founder and Co-Chief Executive Officer

Karsten Voermann – Chief Financial Officer

Conference Call Participants

Jailendra Singh – Truist

Michael Cherny – Bank of America

Eric Sheridan – Goldman Sachs

Doug Anmuth – JPMorgan

Stephanie Davis – SVB Securities

Craig Hettenbach – Morgan Stanley

Jonathan Yong – Credit Suisse

Sandy Draper – Guggenheim Partners

Steve Valiquette – Barclays

Stan Berenshteyn – Wells Fargo

Scott Schoenhaus – KeyBanc

Robert Simmons – D.A. Davidson

Operator

Ladies and gentlemen, and thank you for standing by. Welcome to the GoodRx Third Quarter 2022 Earnings Call. As a reminder, today's conference call is being recorded.

I will now like to introduce your host for today's call, Whitney Notaro, Vice President of Investor Relations. Please go ahead.

Whitney Notaro

Thank you, operator. Good afternoon, everyone and welcome to GoodRx’s earnings conference call for the third quarter of 2022. Joining me today are Doug Hirsch and Trevor Bezdek, our Co-Founders and Co-Chief Executive Officers; and Karsten Voermann, our Chief Financial Officer.

Before we begin, I'd like to remind everyone that this call will contain forward-looking statements. All statements made on this call that do not relate to matters of historical fact should be considered forward-looking statements, including statements regarding management's plans, strategies, goals and objectives, our market opportunity, our anticipated financial performance, the impact of the grocer issue on our business and the impact of macroeconomic conditions on our future results of operation.

These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors. These factors may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements.

Factors discussed in the Risk Factors section of our annual report on Form 10-K for the year ended December 31, 2021, as updated by our quarterly report on Form 10-Q for the quarter ended June 30, 2022, and our other filings with the Securities and Exchange Commission could cause actual results to differ materially from those indicated by the forward-looking statements made on this call.

Any such forward-looking statements represent management's estimates as of the date of this call, and we disclaim any obligation to update these statements, even if subsequent events cause our views to change.